CG Oncology (CGON) executive compensation, 2026 proxy

Arthur Kuan, Chief Executive Officer, was paid $11.9M in 2025, up 7% from $11.2M the year before. The CEO-to-median-employee pay ratio was 40:1, on median employee pay of $301,336.

Filed
April 24, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
7
CEO total pay
$11.9M+7% vs prior year
CEO to median employee
40:1median $301,336
CEO pay in equity
91%$10.8M in awards
CEO Base Salary
$690,0002025 annual base salary
CEO Target Bonus
60%Percentage of base salary
CEO Option Awards
$7,350,515Grant date fair value
CEO Stock Awards
$3,451,884PSU award value
Pay Ratio
40:1CEO to median employee

How Kuan was paid

$11.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary6%Stock awards29%Option awards62%Non-equity incentive3%All other compensation0%

Named executive officers

ExecutiveTotal
Arthur KuanChief Executive Officer$11,928,401
Jim DeToreChief Financial Officer$96,000
Ambaw BelletePresident and Chief Operating Officer$4,815,391
Vijay KasturiChief Medical Officer$3,599,947
Joshua F. PattersonGeneral Counsel, Chief Compliance Officer, and Secretary$2,364,380
Corleen RochePrior Chief Financial Officer$2,322,299
Robert LapetinaPrior Interim Principal Financial and Accounting Officer$645,297

What changed and why

  • $11.9MArthur Kuan received total compensation of $11,928,401 in fiscal 2025 compared to $11,172,793 in the prior year.
  • 60%CEO base salary was set at $690,000 with a target annual bonus of 60% of base salary.
  • Stock and option awards represented the largest components of executive compensation in 2025.
  • The pay ratio of CEO annual total compensation to median employee compensation was approximately 40 to 1.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.